Home Search
Abstracts
Browse
Oral Sessions
Browse
Poster Sessions
Program
Committee
Visit
WebSite
Contact
Us

 

Session 153  Poster Abstracts
TB and HIV Co-Infection: Detection and Treatment Challenges
Wednesday, 1 - 4 pm
Poster Hall
      859 Performance Characteristics of a Whole Blood InterferonG Release Assay in HIV Patients Commencing ART in a High TB Incidence Setting
Julian Elliott*1, S Sarun2, S Chin3, S Chel2, S Huffam1,2, S Huffam1,2, V Saphonn2,3, V Saphonn2,3, J Kaldor1, M French4,5, M French4,5, D Cooper1, and C Mean2
1Natl Ctr for HIV Epidemiology and Clin Res, Univ of New South Wales, Australia; 2Natl Ctr for HIV/AIDS, Dermatology and STDs, Ministry of Hlth, Phnom Penh, Cambodia; 3Natl Inst of Publ Hlth, Ministry of Hlth, Phnom Penh, Cambodia; 4Univ of Western Australia, Perth; and 5PathWest Immunology, Perth, Australia
      860 Comparison of an Interferon-g Release Assay to Conventional Tuberculin Skin Testing for the Diagnosis of Latent TB Infection in HIV-infected Individuals in San Francisco
Annie Luetkemeyer*1,2, Annie Luetkemeyer*1,2, E Charlebois1,2, E Charlebois1,2, L Flores2, D Bangsberg2,3, D Bangsberg2,3, S Deeks2, J Martin2, and D Havlir2
1Ctr for AIDS Prevention Studies, Univ of California, San Francisco, US; 2Univ of California, San Francisco and San Francisco Gen Hosp, US; and 3Epidemiology and Prevention Interventions Ctr, Univ of California, San Francisco, US
      861

Utility of the ELISpot Assay in the Diagnosis of Latent Mycobacterium tuberculosis Infection among HIV-infected Patients with Advanced Immunodeficiency in South Africa
Stephen Lawn*1,2, Stephen Lawn*1,2, N Bangani1, R Wilkinson3,4, R Wilkinson3,4, M Vogt1, M Ntobongwana1, M Badri1, L G Bekker1, and R Wood1
1Desmond Tutu HIV Ctr, Univ of Cape Town, South Africa; 2London Sch of Hygiene and Tropical Med, UK; 3Inst of Infectious Disease and Molecular Med, Univ of Cape Town, South Africa; and 4Wellcome Trust Ctr for Res in Clin Tropical Med, Imperial Coll London, UK
      862

Asymptomatic Pulmonary TB among HIV-infected Adults Screened for the Botswana Isoniazid Preventive Therapy Clinical Trial, 2004-2006
Taraz Samandari*1,2, Taraz Samandari*1,2, T Agizew1, A Arwady1, J Yoon1, S Nyirenda1, B Mosimaneotsile1, Z Tedla1, O Motsamai3, P Kilmarx2, and C Wells2
1BOTUSA Project, Botswana; 2CDC, Atlanta, GA, US; and 3Natl TB Prgm, Ministry of Hlth, Gaborone, Botswana
      863

TB-associated Immune Reconstitution Disease: Incidence, Risk Factors, and Effect within an ART Program in Sub-Saharan Africa
Stephen Lawn*1,2, Stephen Lawn*1,2, L Myer3,4, L Myer3,4, L G Bekker1, and R Wood1
1Desmond Tutu HIV Ctr, Faculty of Hlth Sci, Univ of Cape Town, South Africa; 2London Sch of Hygiene and Tropical Med, UK; 3Sch of Publ Hlth and Family Med, Faculty of Hlth Sci, Univ of Cape Town, South Africa; and 4Columbia Univ Mailman Sch of Publ Hlth, New York, NY, US